GNCA

Genocea Biosciences, Inc.
GNCA

Overview Fund Activity
Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

46 hedge funds and large institutions have $79.4M invested in Genocea Biosciences, Inc. in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 8 closing their positions.

Holders
46
Holders Change
+4
Holders Change %
+9.52%
% of All Funds
0.8%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
11
Reduced
7
Closed
8
Calls
$843K
Puts
$200K
Net Calls
+$643K
Net Calls Change
-$3.23M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$5.85M
2
IC
2
Ikarian Capital
Texas
$468K
3
DC
3
Diametric Capital
Massachusetts
$164K
4
CC
4
Commodore Capital
New York
$6.86M
5
PCM
5
Prelude Capital Management
New York
$102K

Top Sellers

1
Two Sigma Investments
1
Two Sigma Investments
New York
$361K
2
FIA
2
FNY Investment Advisers
New York
$0
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$581K
4
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$0
5
GCP
5
GSA Capital Partners
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TSS
51
Two Sigma Securities
New York
– -$50K -18,578 Closed
GSC
52
Ground Swell Capital
South Carolina
– -$37K -13,616 Closed
Barclays
53
Barclays
United Kingdom
– -$5K -1,763 Closed
VFA
54
Valeo Financial Advisors
Indiana
– -$2K -750 Closed
1 2
3